Search Results - "Wierzbicki, Rafał"

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer: A Phase III Trial by SCAGLIOTTI, Giorgio V, KRZAKOWSKI, Maciej, PAPAI, Zsolt S, KARASEVA, Nina, THONGPRASERT, Sumitra, DALMAU PORTULAS, Elsa, PAWEL, Joachim Von, KE ZHANG, SELARU, Paulina, TYE, Lesley, CHAO, Richard C, GOVINDAN, Ramaswamy, SZCZESNA, Aleksandra, STRAUSZ, Janos, MAKHSON, Anatoly, RECK, Martin, WIERZBICKI, Rafal F, ALBERT, Istvan, THOMAS, Michael, ABRAO MIZIARA, Jose Elias

“…Sunitinib plus erlotinib may enhance antitumor activity compared with either agent alone in non-small-cell lung cancer (NSCLC), based on the importance of the…”
Get full text

Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study by FUCHS, Charles S, MARSHALL, John, BARRUECO, José, MITCHELL, Edith, WIERZBICKI, Rafal, GANJU, Vinod, JEFFERY, Mark, SCHULZ, Joseph, RICHARDS, Donald, SOUFI-MAHJOUBI, Raoudha, WANG, Benjamin

“…This phase III study compared the safety and efficacy of the following three different irinotecan-containing regimens in the first-line treatment of metastatic…”
Get full text

Cetuximab for the Treatment of Colorectal Cancer by Jonker, Derek J, O'Callaghan, Chris J, Karapetis, Christos S, Zalcberg, John R, Tu, Dongsheng, Au, Heather-Jane, Berry, Scott R, Krahn, Marianne, Price, Timothy, Simes, R. John, Tebbutt, Niall C, van Hazel, Guy, Wierzbicki, Rafal, Langer, Christiane, Moore, Malcolm J

“…This open-label trial of the treatment of colorectal cancer with cetuximab, a chimeric monoclonal antibody against the epidermal growth factor receptor (EGFR),…”
Get full text

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial by GRIDELLI, Cesare, CIARDIELLO, Fortunato, LEIGHL, Natasha, WIERZBICKI, Rafal, CINIERI, Saverio, ALAM, Yasmin, SIENA, Salvatore, TORTORA, Giampaolo, FELLETTI, Raffaella, RICCARDI, Ferdinando, MANCUSO, Gianfranco, ROSSI, Antonio, GALLO, Ciro, CANTILE, Flavia, TSAO, Ming-Sound, SAIEG, Mauro, DA CUNHA SANTOS, Gilda, PICCIRILLO, Maria Carmela, DI MAIO, Massimo, MORABITO, Alessandro, PERRONE, Francesco, FELD, Ronald, BUTTS, Charles, GEBBIA, Vittorio, MAIONE, Paolo, MORGILLO, Floriana, GENESTRETI, Giovenzio, FAVARETTO, Adolfo

“…Erlotinib prolonged survival of unselected patients with advanced non-small-cell lung cancer (NSCLC) who were not eligible for further chemotherapy, and two…”
Get full text

Mapping the complex morphology of cell interactions with nanowire substrates using FIB-SEM by Wierzbicki, Rafał, Købler, Carsten, Jensen, Mikkel R B, Lopacińska, Joanna, Schmidt, Michael S, Skolimowski, Maciej, Abeille, Fabien, Qvortrup, Klaus, Mølhave, Kristian

“…Using high resolution focused ion beam scanning electron microscopy (FIB-SEM) we study the details of cell-nanostructure interactions using serial block face…”
Get full text

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial by Ellis, Peter M, Dr, Shepherd, Frances A, Prof, Millward, Michael, Prof, Perrone, Francesco, PhD, Seymour, Lesley, Prof, Liu, Geoffrey, MD, Sun, Sophie, MD, Cho, Byoung Chul, MD, Morabito, Alessandro, MD, Leighl, Natasha B, MD, Stockler, Martin R, Prof, Lee, Christopher W, MD, Wierzbicki, Rafal, MD, Cohen, Victor, MD, Blais, Normand, MSc, Sangha, Randeep S, MD, Favaretto, Adolfo G, MD, Kang, Jin Hyoung, MD, Tsao, Ming-Sound, Prof, Wilson, Carolyn F, MSc, Goldberg, Zelanna, MD, Ding, Keyue, PhD, Goss, Glenwood D, Prof, Bradbury, Penelope Ann, MBBCh

“…Summary Background Dacomitinib is an irreversible pan-HER tyrosine-kinase inhibitor with preclinical and clinical evidence of activity in non-small-cell lung…”
Get full text

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status by GOSS, Glenwood, FERRY, David, ZARENDA, Marc, ARMOUR, Alison A, WIERZBICKI, Rafal, LAURIE, Scott A, THOMPSON, Joyce, BIESMA, Bonne, HIRSCH, Fred R, VARELLA-GARCIA, Marileila, DUFFIELD, Emma, ATAMAN, Ozlem U

“…To compare gefitinib with placebo in chemotherapy naïve patients with advanced non-small-cell lung cancer (NSCLC) and poor performance status. NSCLC patients…”
Get full text

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer by Di Maio, Massimo, Leighl, Natasha B, Gallo, Ciro, Feld, Ronald, Ciardiello, Fortunato, Butts, Charles, Maione, Paolo, Gebbia, Vittorio, Morgillo, Floriana, Wierzbicki, Rafal, Favaretto, Adolfo, Alam, Yasmin, Cinieri, Saverio, Siena, Salvatore, Bianco, Roberto, Riccardi, Ferdinando, Spatafora, Mario, Ravaioli, Alberto, Felletti, Raffaella, Fregoni, Vittorio, Genestreti, Giovenzio, Rossi, Antonio, Mancuso, Gianfranco, Fasano, Morena, Morabito, Alessandro, Tsao, Ming Sound, Signoriello, Simona, Perrone, Francesco, Gridelli, Cesare

“…The TORCH (Tarceva or Chemotherapy) trial randomized patients with advanced non-small-cell lung cancer to first-line erlotinib followed by second-line…”
Get more information

Micro cantilever movement detection with an amorphous silicon array of position sensitive detectors by Contreras, Javier, Costa, Daniel, Pereira, Sonia, Fortunato, Elvira, Martins, Rodrigo, Wierzbicki, Rafal, Heerlein, Holger, Ferreira, Isabel

“…The movement of a micro cantilever was detected via a self constructed portable data acquisition prototype system which integrates a linear array of 32 1D…”
Get full text

Characterization of nanomaterials in food by electron microscopy by Dudkiewicz, Agnieszka, Tiede, Karen, Loeschner, Katrin, Jensen, Louise Helene Soegaard, Jensen, Eric, Wierzbicki, Rafal, Boxall, Alistair B.A., Molhave, Kristian

“…Engineered nanomaterials (ENMs) are increasingly being used in the food industry. In order to assess the efficacy and the risks of these materials, it is…”
Get full text

A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer by Ellis, Peter M, Leighl, Natasha B, Hirsh, Vera, Reaume, M. Neil, Blais, Normand, Wierzbicki, Rafal, Sadrolhefazi, Behbood, Gu, Yu, Liu, Dan, Pilz, Korinna, Chu, Quincy

“…Micro-Abstract Second-line therapy options that improve survival for patients with advanced non–small-cell lung cancer (NSCLC) are needed. This randomized,…”
Get full text

A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer by Paz-Ares, Luis, Bálint, Beatrix, de Boer, Richard H, van Meerbeeck, Jan P, Wierzbicki, Rafal, De Souza, Paul, Galimi, Francesco, Haddad, Vincent, Sabin, Tony, Hei, Yong-jiang, Pan, Yang, Cottrell, Susan, Hsu, Cheng-Pang, RamLau, Rodryg

“…This study evaluated the efficacy, safety, and pharmacokinetics of conatumumab combined with paclitaxel-carboplatin (PC) as first-line treatment for advanced…”
Get more information

Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL) by Hollen, Patricia J., Gralla, Richard J., Stewart, John A., Meharchand, Jacinta M., Wierzbicki, Rafal, Leighl, Natasha

“…Purpose This trial assessed the ability to enhance health-related quality of life (HRQL) and patient-reported outcome (PRO) evaluation in trials and patient…”
Get full text

Cell motility, morphology, viability and proliferation in response to nanotopography on silicon black by Łopacińska, Joanna M, Grădinaru, Cristian, Wierzbicki, Rafal, Købler, Carsten, Schmidt, Michael S, Madsen, Martin T, Skolimowski, Maciej, Dufva, Martin, Flyvbjerg, Henrik, Mølhave, Kristian

“…Knowledge of cells' interactions with nanostructured materials is fundamental for bio-nanotechnology. We present results for how individual mouse fibroblasts…”
Get more information

A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy – Canadian Cancer Trials Group IND 211 by Morris, Donald, Tu, Dongsheng, Tehfe, Mustapha Ali, Nicholas, Garth Andrew, Goffin, John R., Gregg, Richard William, Shepherd, Frances A., Murray, Nevin, Wierzbicki, Rafal, Lee, Christopher W., Kuruvilla, Sara, Keith, Bruce, Ahmed, A, Blais, Normand, Goss, Glenwood D., Korpanty, Grzegorz, Sederias, Joana, Laurie, Scott Andrew, Seymour, Lesley, Bradbury, Penelope Ann

“…Abstract only…”
Get full text

Electrostatic Silicon Microgripper with Low Voltage of Actuation by Wierzbicki, Rafal, Adda, Cedric, Hotzendorfer, Harald

“…In this paper we present design considerations and results of experiments conducted in order to lower maximum driving voltage of a silicon microgripper's…”
Get full text

Use of Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer (MCRC): A Post-Hoc Analysis of the Glutox Study by Benoit, Samson, Pierre, Dube, Nathalie, Aucoin, Rafal, Wierzbicki, Jean, Maroun, Richard, Letourneau, Eric, Chen, Danielle, Charpentier, Felix, Couture, Mark, Vincent, Jean, Lepine, Pierre, Whitlock, Karine, Alloul, Francois, Leblond, Wei, Zhou, Petr, Kavan

Get full text

Efficacy, Safety and Patient-Reported Outcomes of Oxaliplatin-Based Chemotherapy in Elderly Patients with Colorectal Cancer (CRC): A Post-Hoc Analysis of the Glutox Study by Benoit, Samson, Pierre, Dube, Nathalie, Aucoin, Rafal, Wierzbicki, Jean, Maroun, Richard, Letourneau, Eric, Chen, Danielle, Charpentier, Felix, Couture, Mark, Vincent, Jean, Lepine, Pierre, Whitlock, Helene, Grassin, Francois, Leblond, Wei, Zhou, Petr, Kavan

Get full text

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining by Wierzbicki, Rafal, Jonker, Derek J., Moore, Malcolm J., Berry, Scott R., Loehrer, Patrick J., Youssoufian, Hagop, Rowinsky, Eric K.

“…Summary Purpose To determine antitumor activity of cetuximab monotherapy in patients with refractory metastatic colorectal carcinoma (mCRC) with lack of…”
Get full text

Hydrides of Laves phases intermetallic compounds synthesized under high hydrogen pressure by Filipek, Stanislaw M., Paul-Boncour, Valerie, Kuriyama, Nobuhiro, Takeichi, Nobuhiko, Tanaka, Hideaki, Liu, Ru-Shi, Wierzbicki, Rafal, Sato, Ryutaro, Kuo, Hui-Tung

“…High hydrogen pressure technique up to 1.2 GPa has been used for synthesis of novel hydrides in RFe 2 Laves phases (R = Gd, Tb, Dy, and Ho) compounds as well…”
Get full text